More Articles


Reclaim The Glory Of Value

Adam Chapman, (Jan 8, 2019)

Value has become a buzzword, but its importance cannot be overstated. How do we ensure its survival?
Access and Evidence

RWE: The Missing Link

Nicola Davies, (Jan 7, 2019)

Linking real-world datasets is essential to deliver true insights
Patients and Medical

Up Close And Personal

Lucy Fulford, (Jan 7, 2019)

Ian Talmage’s experience as a patient and carer has left an indelible mark on his life and his career.

What Can Pharma Expect in 2019?

The eyeforpharm..., (Jan 7, 2019)

Our look at the biggest trends hitting the industry over the coming 12 months
Access and Evidence

Gold Standard: Standardizing RWD

Nicola Davies, (Jan 4, 2019)

If real-world data is to deliver on its promise, it needs to be standardized

Releasing Pharma’s Potential

Adam Chapman, (Jan 3, 2019)

The industry has a new frontier in its sights. LEO Pharma’s CEO provides us with a blueprint to get there.

Commercialising Data: The Great Conundrum

Ross Davies, (Jan 1, 2019)

Big data might be everywhere, but its commercial use across pharma is still wanting. Sales and advanced analytics shouldn’t be mutually exclusive

You Had Me At Hello

Lucy Fulford, (Jan 1, 2019)

Sophisticated customer engagement is a not a nice-to-have but a core expectation in 2019. How far along is pharma?

It’s All About The Journey, Not The Destination

Lucy Fulford, (Jan 1, 2019)

Gone are the days of dumping content and hoping HCPs engage with it. A personalized journey is the roadmap to success
Access and Evidence

Blockchain: Solution Or Snake Oil?

Ross Davies, (Dec 19, 2018)

The potential of blockchain to better manage RWE and access makes it an exciting prospect. However, pharma first needs to get its head around the practical application.